[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100617838":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":29,"locations":11,"responsibleParty":35,"collaborators":11,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":41,"sex":47,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":11,"studyType":53,"phases":54,"briefSummary":56,"conditions":57,"keywords":11,"overallStatus":59,"whyStopped":11,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":11},{"fullName":5,"class":6},"Pusan National University Yangsan Hospital","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm 1: Experimental Group (850nm PBM + Standard Rehabilitation)","EXPERIMENTAL",null,[13,14],"Device: photobiomodulation (PBM)","Other: control group-receive speech therapy",{"label":16,"type":17,"description":11,"interventionNames":18},"Arm 2: Control Group ( Standard Rehabilitation)","SHAM_COMPARATOR",[14],[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":11},"DEVICE","photobiomodulation (PBM)","Experimental Group: Participants will receive iSyncWave transcranial photobiomodulation (tPBM) and speech therapy, with 20 minutes per modality per session, once daily, 5 days per week, for 4 weeks, totaling 20 sessions of combined intervention. During the intervention period, changes in concomitant medications and concurrent therapies will be monitored and recorded; any modifications to medications or therapies must be documented in detail.",[9],{"type":6,"name":26,"description":27,"armGroupLabels":28,"otherNames":11},"control group-receive speech therapy","Participants will receive speech therapy at a frequency of 20 minutes per session, once daily, 5 days per week, for 4 weeks, with a total of 20 sessions.",[9,16],[30],{"name":31,"role":32,"phone":33,"phoneExt":11,"email":34},"Il Yong Shin","CONTACT","010-6535-0310","rmshin01@gmail.com",{"type":36,"investigatorFullName":37,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Yong-il Shin","PhD","100617838","the-effect-of-pbm-on-the-electrical-activity-of-the-brain-in-stroke-patients-100617838",false,"NCT07323823","The Effect of PBM on the Electrical Activity of the Brain in Stroke Patients","The Effect of 850 nm Photobiomodulation Therapy (PBM) on the Electrical Activity of the Brain in Stroke Patients","PBM","Inclusion Criteria:\n\n* Patients diagnosed with ischemic or hemorrhagic stroke by a specialist. Patients in the recovery phase within 1 year after onset; those with confirmed clinical functional impairment upon assessment, who are conscious and able to cooperate with PBM stimulation and evaluations.\n\nAdult patients (≥ 18 years old) ，less than 80 years old，who have signed the informed consent form, or patients with proxy consent.\n\nExclusion Criteria:\n\n* Individuals with photosensitive skin at risk of developing urticaria or dermatitis.\n\nPatients judged to have an unstable surgical site following hemorrhagic stroke-related surgery.\n\nPregnant or lactating individuals. Individuals with a history of seizures. Individuals who have participated in clinical studies twice or more in the same year or in other clinical studies within 6 months.\n\nOther individuals with clinically significant findings deemed medically inappropriate for the study by the principal investigator or responsible researcher.","ALL","18 Years","80 Years",{"count":51,"type":52},66,"ESTIMATED","INTERVENTIONAL",[55],"NA","The Effect of Low-Level Light Therapy on the Electrical Activity of the Brain in Stroke Patients",[58],"Post-stroke Aphasia","NOT_YET_RECRUITING","2025-12-23",{"date":62,"type":63},"2026-01-07","ACTUAL",{"date":65,"type":52},"2025-12-31",{"date":67,"type":52},"2026-12-31",{"name":5,"class":6}]